Autoimmune diseases increase the risk of cardiovascular disease
Time of Update: 2022-09-09
In a large epidemiological study from the University of Leuven, researchers showed that patients with autoimmune diseases had a higher risk of developing cardiovascular disease than individuals without autoimmune diseases.
Give full play to the advantages of modern scientific research and help the diversified development of the industry
Time of Update: 2022-09-03
. (Zhongjin Village) Responsible editor: Xiao Zhihan Review: Peng Zonglu With the development needs of the bird's nest industry entering a new stage of scientific research and innovation, Yanzhiwu, as a leading brand in the industry, has always attached great importance to R&D and innovation, actively adapting to the trend of the times, and constantly gaining insight into user needs.
New research shows that humans have amazing 'nutritive intelligence
Time of Update: 2022-05-26
The international study, led by the University of Bristol in the UK, aimed to re-examine and test the widely accepted idea that humans evolved to prefer energy-dense foods and that our diets simply consist of eating a variety of different foods balance .
Guangxi holds a symposium of experts on pesticide production license review
Time of Update: 2022-02-23
Guo Xuquan, deputy director of the Agriculture Department of the Autonomous Region, attended the meeting and delivered a speech .
Retinal Research Laboratory has made new progress in the study of glial cell activation mechanism in glaucoma
Time of Update: 2022-02-22
After years of painstaking research, the research group of Professor Wang Zhongfeng from the Institute of Brain Science of Fudan University/State Key Laboratory of Medical Neurobiology has made new research progress in the activation mechanism of the retinal glial cell network in experimental glaucoma.
Eight-year follow-up of more than one million women: oral contraceptives and hormone replacement therapy need to be cautious
Time of Update: 2022-01-09
1), compared with subjects without gout, subjects diagnosed with gout have late menarche, early menopause, shorter reproductive period, use of OC, HRT, and breastfeeding ≥1 The proportion of the year is higher .
The US Congress released a drug pricing survey report, exposing pharmaceutical companies to manipulate prices for huge profits
Time of Update: 2021-12-29
According to the report, “the committee’s investigation found that the company spent a large portion of its R&D expenditure on research aimed at expanding market monopoly, supporting the company’s marketing strategy, and curbing competition .
According to the 269-page report, the three insulin companies adopted strategies to maintain monopoly pricing and resist competition from biosimilar drugs .
[The Lancet] Subvert the traditional detection method and achieve a new breakthrough in the early screening of prostate cancer
Time of Update: 2021-10-02
The results of this new study are based on "Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): A prospective, population-based, randomised, open-label, non-inferiority trial" research has been published in "The Lancet Oncology", and the results show that it was developed by researchers from Karolinska Institutet Stockholm3 can be an important supplement .
Thailand's mangosteen exports increased by 20%, and Indonesia became its biggest rival
Time of Update: 2021-09-18
Export fruit epidemic prices Entering September, Thailand's Kaitai Research Center believes that from September to December, Thailand's mangosteen export volume will slow down due to the decrease in supply .
New barium and strontium descaling technology in Shengli Oilfield solves production problems
Time of Update: 2021-08-15
Under the new technology of Shengli Petroleum Engineering Technology Research Institute, it was easy to solve the problem without moving the pipe string, and the daily output of 5 tons was restored.
Barium and strontium scale is a type of scale that is difficult to deal with in oil and gas field production.
The world's first think tank report that exposes the truth about the U.S. fight against the epidemic is released
Time of Update: 2021-08-13
The report believes that under the double blow of the virus and man-made disasters, the new crown pneumonia epidemic in the United States has not been effectively controlled so far, and the US government’s anti-scientific and perverse common sense in epidemic prevention and control, traceability investigations and other aspects have become the "anti-epidemic failed country.
Big coffee interview with Professor Qin Yaqin: Molecular markers help B-ALL diagnosis and treatment, WT1 can be used as an effective indicator for MRD monitoring
Time of Update: 2021-08-10
During this period, Yimaitong was fortunate to invite researcher Qin Yaqin from Peking University People's Hospital to share the molecular markers of B-ALL and the clinical application of WT1 in MRD monitoring .
” Researcher Qin Yaqin pointed out that molecular markers are essential for the diagnosis, prognosis, targeted therapy and MRD monitoring of B-ALL .
Eli Lilly and MiNA develop a new drug based on the saRNA platform, Bojian and Ca
Time of Update: 2021-05-23
On May 11, Eli Lilly and MiNA Therapeutics, an RNA activation therapy company, announced a global research collaboration to develop new drug candidates using MiNA's proprietary small molecule activated RNA (saRNA) technology platform.
Interpretation of Nature Sub-Journal: Scientists have discovered that humans suffer from multiple diseases or have common
Time of Update: 2021-05-03
Recently, in a research report titled "Plasma metabolites to profile pathways in noncommunicable disease multimorbidity" published in the international journal Nature Medicine, scientists from the University of Cambridge and other institutions have identified through research that it can increase individual suffering from one or more diseases.
Ganli Pharmaceutical's GZR18 clinical application was accepted by NMPA
Time of Update: 2021-04-27
For obesity and overweight indications, currently, no GLP-1 receptor agonist drug that is injected once a week has been approved for obesity and overweight treatment globally.